830
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Improving the quality of pretreatment staging in patients with esophageal carcinoma – a fast track study

, , , &
Pages 362-367 | Received 08 Jul 2011, Accepted 16 Sep 2011, Published online: 24 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Minoru Tomizawa, Fuminobu Shinozaki, Aika Ozaki, Akira Baba, Yoshiya Fukamizu, Futoshi Matsunaga, Takao Sugiyama, Shigenori Yamamoto, Makoto Sueishi & Takanobu Yoshida. (2013) Diffusion-weighted imaging and diffusion-weighted whole-body imaging with background body signal suppression for characterizing esophageal cancer: a case report. International Medical Case Reports Journal 6, pages 95-98.
Read now

Articles from other publishers (1)

MINORU TOMIZAWA, FUMINOBU SHINOZAKI, KAZUNORI FUGO, TAKAFUMI SUNAOSHI, DAISUKE KANO, SATOMI TANAKA, AIKA OZAKI, ERIKO SUGIYAMA, MISAKI SHITE, RYOUTA HAGA, AKIRA BABA, YOSHIYA FUKAMIZU, TOSHIYUKI FUJITA, SATOSHI KAGAYAMA, RUMIKO HASEGAWA, AKIRA TOGAWA, YOSHINORI SHIRAI, NOBORU ICHIKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, TAKASHI KISHIMOTO & NAOKI ISHIGE. (2016) Diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion of gastrointestinal cancers. Molecular and Clinical Oncology 5:1, pages 44-48.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.